Skip to content

Clinical trials

Heart Diseases trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20182
20191
20204
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
Chinese University of Hong Kong3
Abbott Medical Devices1
Alexion Pharmaceuticals, Inc.1
CSL Behring1
GlaxoSmithKline1
Hong Kong Children's Hospital1
Medtronic Cardiac Rhythm and Heart Failure1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases13
Cardiovascular Diseases6
Heart Failure4
Atrial Fibrillation3
Atherosclerosis2
Acute Coronary Syndrome1
Bundle-Branch Block1
Cardiac Conduction System Disease1
Cardiomyopathies1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.